Exclusive: US FDA to ask Sarepta to stop shipments of gene therapy Elevidys, source says Reuters Sarepta shares plunge 40% as future of its gene therapy appears at risk CNBC FDA to Ask Sarepta to Stop Shipping Muscular Dystrophy Drug Elevidys The New York Times Third death from a Sarepta gene therapy BioCentury FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market Bloomberg …
Read More »Tag Archives: gene
Sarepta stock falls on FDA gene therapy Elevidys comment
Douglas Ingram, president and chief executive officer of Sarepta Therapeutics Inc., during the Forbes Healthcare Summit in New York, US, on Tuesday, Dec. 5, 2023. Michael Nagle | Bloomberg | Getty Images Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy treatment appeared at risk. The Food and Drug Administration will …
Read More »Sarepta Says Another Patient Died After Receiving Gene Therapy – Bloomberg
Sarepta Says Another Patient Died After Receiving Gene Therapy Bloomberg Patient dies in Sarepta gene therapy trial, adding to safety concerns STAT Sarepta Therapeutics lays off one-third of workforce in drastic cost-cutting The Boston Globe Third death from a Sarepta gene therapy BioCentury Sarepta Therapeutics Stock Is Surging After The Bell: What’s Going On? Yahoo Finance Source link
Read More »Sarepta to cut 500 jobs, add black-box warning on gene therapy – Reuters
Sarepta to cut 500 jobs, add black-box warning on gene therapy Reuters Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label Sarepta Therapeutics Sarepta Soars as Gene Therapy Stays on Market With Warning Bloomberg Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning Fierce Biotech Sarepta Therapeutics Halts …
Read More »Sarepta Soars as Gene Therapy Stays on Market With Warning – Bloomberg
Sarepta Soars as Gene Therapy Stays on Market With Warning Bloomberg Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label Sarepta Therapeutics Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning Fierce Biotech Sarepta Therapeutics Halts ELEVIDYS Shipments for Non-Ambulatory DMD Patients Yahoo Finance Sarepta Therapeutics lays off …
Read More »Gene Key to MS Immune Regulation Discovered
Summary: New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies. In a mouse model of multiple sclerosis, loss of Egr-1 led to reduced regulatory T cell activity and heightened inflammation. The study showed Egr-1 directly boosts the expression of Foxp3, a protein essential for Treg cells, via the TGF-β …
Read More »In a first, congenital deafness in teens and adults treated with new gene therapy
Up to 3 in every 1,000 newborns has hearing loss in one or both ears. While cochlear implants offer remarkable hope for these children, it requires invasive surgery. These implants also cannot fully replicate the nuance of natural hearing. But recent research my colleagues and I conducted has shown that a form of gene therapy can successfully restore hearing in …
Read More »